Biomarin Pharmaceutical Inc at Citi BioPharma Conference Transcript
Hello. Thank you all for coming again to the 18th Annual Citi Biopharma Conference. Happy to have on stage with me from BioMarin, certainly been an exciting last few years, biggest commercial launch in history with Voxzogo the upcoming or ongoing launch as of just recently, launch of Roctavian for hemophilia A and of course, a large portfolio of ultra-rare diseases.
Questions & Answers
Could you start by walking us through BioMarin, its history and really these transformative recent years?
Great. Thanks. Thanks, David. Thanks for having us. Thanks for participating, everyone. And yes, BioMarin has been on a steady growth journey throughout our 25-year history. We grew up around mostly ultra-orphan therapies. These are ultra-rare metabolic disorders, very small patient populations, very
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
